Mega Genomics Limited

As of December 31, 2025, Mega Genomics Limited has 224.30M shares outstanding.

As of December 31, 2025, Mega Genomics Limited maintains a current ratio of 3.64, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Mega Genomics Limited's stock has declined approximately 0.35% over the past 52 weeks. The 50-day moving average sits at 7.08, while the 200-day moving average is 7.45.

As of December 31, 2025, Mega Genomics Limited holds 484.89M in cash and equivalents against 32.69M in total debt, resulting in a net debt position of -441.66M. Total book value stands at 679.91M, with working capital of 586.96M providing operational flexibility.